Founded in 2003, Horus Pharma is an independent French pharmaceutical laboratory specializing in ophthalmology that is part of the French and European landscape.
Horus Pharma develops, patents and markets products for eye and eyelid health.
Horus Pharma is active in the majority of ophthalmology-related segments, developing practical innovations that combine efficacy and safety.
Focused on patient safety, the Laboratory has built up recognized know-how in the development of high-performance solutions and preservative-free product lines.
Recording double-digit growth since its creation, Horus Pharma closed 2022 with a turnover of €85 million.
Horus Pharma is now a key player in its markets and is continuing its dynamic policy of European expansion. Its headquarters are located in France in the Alpes-Maritimes. The company distributes its products in France, and internationally through its subsidiaries in Belgium, the Netherlands, Luxembourg, Spain, Switzerland and Scandinavia, as well as in many other countries through distribution agreements.
Since the creation of the Laboratory, Horus Pharma has been a pioneer in the development of preservative-free formulations and products and has also extended its expertise to dermatology and cosmetics.